Vaccines for enteric diseases: A meeting summary

Duncan Steele; Mark Riddle; Lillian Van De Verg; Louis Bourgeois

doi:10.1586/erv.12.9

Vaccines for enteric diseases: A meeting summary

Duncan Steele^*, Mark Riddle, Lillian Van De Verg, Louis Bourgeois

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Abstract

The 6th Vaccines for Enteric Diseases Symposium was held in Cannes, France, on 14-16 September 2011, drawing approximately 200 vaccine developers, academics and public health experts globally. Infectious diarrhea is a worldwide problem with high mortality and morbidity, particularly among children in the developing world. The WHO estimated approximately 8.8 million deaths in 2008 in young children aged 1-59 months, of which almost 2 million could be attributed to diarrheal illnesses - more than malaria, HIV/AIDS and TB combined. New breakthroughs in vaccine development, early clinical trials for the enterotoxigenic Escherichia coli, Shigella, noroviruses and conjugate typhoid vaccines, and updates on the implementation of rotavirus, cholera and typhoid vaccines were reported.

Original language	English
Pages (from-to)	407-409
Number of pages	3
Journal	Expert Review of Vaccines
Volume	11
Issue number	4
DOIs	https://doi.org/10.1586/erv.12.9
State	Published - Apr 2012
Externally published	Yes

Keywords

Escherichia coli
Shigella
diarrhea
rotavirus

Access to Document

10.1586/erv.12.9

Cite this

@article{b4a50f2dd7544643b395e65a03072639,

title = "Vaccines for enteric diseases: A meeting summary",

abstract = "The 6th Vaccines for Enteric Diseases Symposium was held in Cannes, France, on 14-16 September 2011, drawing approximately 200 vaccine developers, academics and public health experts globally. Infectious diarrhea is a worldwide problem with high mortality and morbidity, particularly among children in the developing world. The WHO estimated approximately 8.8 million deaths in 2008 in young children aged 1-59 months, of which almost 2 million could be attributed to diarrheal illnesses - more than malaria, HIV/AIDS and TB combined. New breakthroughs in vaccine development, early clinical trials for the enterotoxigenic Escherichia coli, Shigella, noroviruses and conjugate typhoid vaccines, and updates on the implementation of rotavirus, cholera and typhoid vaccines were reported.",

keywords = "Escherichia coli, Shigella, diarrhea, rotavirus",

author = "Duncan Steele and Mark Riddle and {Van De Verg}, Lillian and Louis Bourgeois",

year = "2012",

month = apr,

doi = "10.1586/erv.12.9",

language = "English",

volume = "11",

pages = "407--409",

journal = "Expert Review of Vaccines",

issn = "1476-0584",

number = "4",

}

TY - JOUR

T1 - Vaccines for enteric diseases

T2 - A meeting summary

AU - Steele, Duncan

AU - Riddle, Mark

AU - Van De Verg, Lillian

AU - Bourgeois, Louis

PY - 2012/4

Y1 - 2012/4

N2 - The 6th Vaccines for Enteric Diseases Symposium was held in Cannes, France, on 14-16 September 2011, drawing approximately 200 vaccine developers, academics and public health experts globally. Infectious diarrhea is a worldwide problem with high mortality and morbidity, particularly among children in the developing world. The WHO estimated approximately 8.8 million deaths in 2008 in young children aged 1-59 months, of which almost 2 million could be attributed to diarrheal illnesses - more than malaria, HIV/AIDS and TB combined. New breakthroughs in vaccine development, early clinical trials for the enterotoxigenic Escherichia coli, Shigella, noroviruses and conjugate typhoid vaccines, and updates on the implementation of rotavirus, cholera and typhoid vaccines were reported.

AB - The 6th Vaccines for Enteric Diseases Symposium was held in Cannes, France, on 14-16 September 2011, drawing approximately 200 vaccine developers, academics and public health experts globally. Infectious diarrhea is a worldwide problem with high mortality and morbidity, particularly among children in the developing world. The WHO estimated approximately 8.8 million deaths in 2008 in young children aged 1-59 months, of which almost 2 million could be attributed to diarrheal illnesses - more than malaria, HIV/AIDS and TB combined. New breakthroughs in vaccine development, early clinical trials for the enterotoxigenic Escherichia coli, Shigella, noroviruses and conjugate typhoid vaccines, and updates on the implementation of rotavirus, cholera and typhoid vaccines were reported.

KW - Escherichia coli

KW - Shigella

KW - diarrhea

KW - rotavirus

UR - http://www.scopus.com/inward/record.url?scp=84860594754&partnerID=8YFLogxK

U2 - 10.1586/erv.12.9

DO - 10.1586/erv.12.9

M3 - Article

C2 - 22551024

AN - SCOPUS:84860594754

SN - 1476-0584

VL - 11

SP - 407

EP - 409

JO - Expert Review of Vaccines

JF - Expert Review of Vaccines

IS - 4

ER -

Vaccines for enteric diseases: A meeting summary

Abstract

Keywords

Access to Document

Fingerprint

Cite this